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By far the majority of studies and speculations on metabolism in man and
animals have been concerned with the fate of proteins, fats, and carbohydrates.
Even when interest was awakened in enzymes and vitamins, the transformation
of the organic substances was still studied. Gradually, however, various methods
of the analysis and measuring instruments used have been so perfected that
other problems can now be included in the field of biological and medical re-
searches, namely, the significance of inorganic substances for the living organism.
These substances, which can often be demonstrated only as traces, have
opened up new fields for our analytical investigations. It is clear today that even
substances occurring in insignificant amounts have a vital importance.
Many of different ions have been repeatedly investigated and a number of
their functions were clarified early. This is particularly the case with calcium,
whose function in the construction of our bones and teeth, in the mechanism of
coagulation, and in numerous nerve and muscle processes, etc., is not unknown.
Sodium and potassium, as essential ions in the maintenance of the external and
internal environments of the cell, have also received a considerable attention.
The significance of iron is well known, not merely as a part of the oxygen-
transporting haemoglobin of the red blood corpuscles, but also in those enzymes
necessary for the oxygen turn-over in the cell. In addition to the above-men-
tioned substances, numerous others are found in varying amounts, such as
copper, cobalt, zinc, manganese, magnesium, molybdenum, cadmium, and
fluorine.
In the present paper an account will be given of the significance and occur-
rence of copper and zinc in blood, with particular attention to the variations
found in haematological and neurological diseases.
Copper is found throughout the earth's crust. It has been known for a very
long time, for example in alloys such as bronze, which has been used for
thousands of years. Salts of copper were employed already in ancient Babylon,
in the treatment of various eye diseases.
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Table 1. Some figures for iron, copper and zinc in the human body.
(Calculated from the literature)
•
I
I Total amount Serum Corpuscle IntracorpuscularDaily of metal in value red
intake mg I huma~ body value cells protein bound metal inper p.g 0/0 per p.g 0/0 0/0
I
Fe ...... 10-25 3-5 120 100000 IHaemoglobin 0.34 Fe
I Cu .. ·.. · 2-5 0.1-0.15 120 100 I Haemocuprein 0.34 Cu
I Zn ...... 10-15 2 130 1300 Carbonic Anhydrase 0.33 Zn
It has been known for almost two centuries that copper is present in both
animal and plant materials. It was assumed, however, that its presence was
due to contamination, and not because it was a naturally-occurring substance.
It was not until the turn of the century that copper was recognized as an essen-
tial constituent of the living organism. After that observation, many workers
began to study copper metabolism and its significance in the normal organism,
as well as variations in the copper content associated with different pathological
states.
The copper content of the normal human organism is about 150 mg of
copper. Most of this is found in the liver, kidneys, heart and brain, while only
relatively small amounts are found in the muscles, adrenal glands, bones and
blood.
In the blood stream, copper is found in both plasma and blood corpuscles.
The copper content of whole blood is reported as being around 100 micrograms
per 100 ml. Women appear to have somewhat higher values than men.
About 90 per cent of the copper in plasma is bound to proteins, normally
to the globulins, in particular to alpha, 0'2 to form a compound called cerulop-
lasmin. Most of the copper in the erythrocytes is likewise bound to proteins,
forming a compound called erythrocuprein. The biochemical nature of the
copper-containing substances found in the other tissues and body fluids is still
unknown, but many copper-containing enzymes have been isolated from various
tissues, as indicated in Table 2.
Most investigators have been interested only in the amount of copper in
serum, but determinations of copper in both whole blood, erythrocytes and
leucocytes would also appear to be of some clinical interest.
By far the majority of these investigators agree that under normal condi-
tions, determinations of copper in whole blood give only about 80 per cent of
the value of copper found in an equal volume of serum.
There are only few determinations of the copper content of erythrocytes;
but some investigators claim to have demonstrated that the copper content in
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Table 2. Mammalian Cuproproteins and Cuproenzymes.
305
Material
Cuproproteins :
Cerebrocuprein I .
Erythrocuprein (hemocuprein)···············
Hepatocuprein·· .. ······· .. ··· .. · .. ·· .. ·.. ·.. · ..
Milk cuproprotein .
Cuproenzymes :
Ceruloplasmin····· .. · ·· ·· ..
Cytochrome oxidase .
Phenol oxidase (tyrosinase) .
Beta-mercaptopyruvate transsulfurase
Butyryl coenzyme A dehydrogenase
Uricase ..
Copper %
0.25-0.30
0.32-0.36
0.31-0.41
0.19
0.31-0.34
0.006
0.2
0.17
0.35
0.06
Mol. Wt.
35 000
3:\ 000
35 000
?
151 000
?
34 000 (110000)
35 000
120 000-222 000
110 000
erythrocytes amounts to only approximately 70 per cent of the amount of copper
found in an equal volume of serum.
Only few investigators have attempted to determine the copper content of
leucocytes. The amount found is very small; determined per 109 leucocytes, it
is less than one per cent of the amount found in 100 ml serum.
Many factors appear to influence the concentration of copper in tissue, for
example diet, age, hormones, pregnancy, and a variety of diseases.
As already mentioned, under normal conditions a greater copper content
is found in the blood of women than of men.
During pregnancy, there is a steady rise in the amount of serum copper
from the eighth week until term, and thereafter a fall to normal value, reached
about the 10th week after delivery. This rise in serum copper content is accom-
panied by a corresponding rise in the concentration of ceruloplasmin. If the
infant's copper content is examined at birth, a very low value is found in the
serum, corresponding to a low ceruloplasmin content. The amount of copper
which does not take part in the formation of ceruloplasmin, is the same in
mother and infant. Not until the second month of life does the infant attain the
normal copper content of blood and at the same time the normal content of
ceruloplasmin. The interpretation of this must be that the infant is unable to
form this complex protein-copper compound during foetal life.
If we now look at the shifts in values noted in various pathological states,
we find a variety of data on the copper content of both serum and blood cor-
puscles. Table 3 shows the values found in our laboratory.
By far the majority of reports on copper metabolism in pathological states
come from studies of serum and urine. This obviously does not give a picture
3
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Table 3. The copper content of serum, whole blood, erythrocytes and leucocytes
serum in normal and
Serum I Whole blood I Erythrocytes
Diagnosis n Gamma pr 100 ml
Average
I
Average I Average(min-max) (min-max) (min-max)
Controls, male ........................ 100 111 (82-176) I
- female ........................... 100 122 (80-189)
- male + female*·· .. ···· .. ·.. ·· 94 117 (84-162)
- - -
*............... 25 118 (87-156)
- - -
............... 66 117 (92-156) 96 (70-120) 79 (53-107)
Anemia simplex ..................... 5 129 (108-149) 108 (88-128) 100 (88-122)
Sec. Anemia (Ulcus ventriculi)··· 2 131 (109-152) 117 (98-136) 98 (82-114)
Anemia perniciosa .................. 18 129 (109-165) 105 (93-126) 96 (83-116)
-
:1Leukemia. acute················""· 1 212 (196-2281 : 177 (162-1921 I 125 (72-138)- chr............................... 186 (129-220) 145 (99-182) 102 (83-121)
Va:~~~i~e~~~~.l..~.i~.~~~.~~~~~.~~.I 56
1
118 I(75-153) I
Mb. Basedowii··.. ...... ......... ..... I 4
1
196 (122-282) 1 110 (82-156) I 80 (67-102)
Polyarthritis chr. ..................... I 15
1
158 (109-224) I 123 (92-159) I 82 (54-102)
Tuberculosis pulm................... I 12
1
115 (79-171) I 101 (74-131) I 80 (62-102)
Various neurol. d~·· ..······i 551 124 195-1621 1
I- - - * 66 122 (90-137)
Epilepsy *
:::::::::::::::::::::: I 109 I 133 (86-207) I (7D-1591- 25
1
139 (82-216) 112 80 (52-112)
Multiple Sclerosis'" .................. 78 124 (92-176)
- -
* .................. 10 117 (l03-133)
- -
.................. 22 130 (103-171) 119 (99-131) 111 (87-126)
Psychoses and Neurosis*.......... 59 I 119 (85-174)
- - -
......... 15
1
118 (96-172) 95 (72-124) 82 (51-108)
Schizophrenia·· .... · .................... 10 132 (92-200) 94 (70-136) 80 (56-110)
Cancer canal. dig. .................. 4 168 (147-183) 127 (114-143) 69 (66-81)
- gen. fern. . ................. 10 20i (146-249) 154 (126-200) 69 (49-80)
-
mammae ..................... 3 192 (152-241) 160 (120-201) 114 (106-123)
Gmvidita' (32-36 whl. ·········1 :1 258 (200-3121 I 173 (144-200) I 83 (67-100)4 weeks post parturn'"'''''''''''' 130 (122-138) 98 (90-107) I 82 (70-91)
* Cl. M. Plum & S. E. Hansell: Acta Psych. et Neurol. Scalld. Suppl. 148, 1960.
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in normal and pathological cases. The ceruloplasmin and copper-oxidase content of
pathological cases.
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Leucocytes Ceruloplasmin Copperoxidase
n Gamma pr 109 cells n mg ·pr 100 ml n Extinction 610 m,u
Average (min-max) Average (min-max) Average (min-max)
94 0.281 (0.192-0.405)
25 37.76 (28.4-58. 6) 25
I
0.278 (0.195-0.399)
60 0.91 (0-1.59) 25 37.80 (28.3-59.4) 25 0.284 (0.191-0.399)
5 0.97 (0.69-1.34)
2 0.90 (0.34-1.46)
16 0.98 (0.26-1.51) 12 0.279 (0.142-0.351)
--
I I I I I
2 0.76 (0-1.52)
6 0.79 (0-1.09)
I I I I 56 I 0.293 (0.189-0.395)
4
I
0.96 (0-14.7) I \ I I
11 I 0.92 (0-1.42) I I I I
12 ] 0.96 (0-1.59) I I I II
I I I (28.0-57.7) I
55
I
0.271 (0.181-0.365)
66 38.98 66 0.279 (0.199-0.392)
I
i
I 1
'09
I
0.311 (0.190-0.467)
25 0.86 (0-1.57) 25 38.1 (23.2-61.2) 25 0.299 (0.215-0.455)
--
I74 0.215 (0.144-0.295)
10 22.68 (18.2-20.6) 10
I
0.167 (0.148-0.215)
12 0.99 (0.49-1.78) 22 23.36 (18.0-27.6) 22 0.176 (0.132-0.233)
--
59 0.274 (0.198-0.425)
15 0.96 (0-1.37)
10 0.93 (0-1.49) 10 38.82 (26.8-58.9) 10 0.289 (0.180-0.412)
4 0.89 (0.29-1.23)
I I
4 0.78 (0-0.97) 4 53.12 (40.9-71.0) 4 0.393 (0.276-0.472)
3 1.02 (0.38-1.56) 3 I 51.0 (40.12-66.84) 3 0.369 (0.255-0.463)
3
I
0.94 (0.29-1.39)
I I I I2 0.93 (0.65-1.21)
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of the total copper metabolism of the organism, and further studies, elucidating
the variations in copper in various tissues, must be awaited, before a complete
picture can be formed of the changes in copper metabolism during pathological
states.
On the basis of our present knowledge, we may distinguish between states
in which there is hypercupraemia, hypocupraemia and a normal level of copper.
These evaluations are based on the copper content of the serum, and only the
serum. Over and above this are the variations that may occur in copper content
of erythrocytes and leucocytes, variations in copper oxidase activity and in the
content of ceruloplasmin.
In our laboratory we have been interested during the past few years in
these variations in a number of patients suffering from multiple sclerosis, and
have also supplemented our material by a number of studies of other neurologi-
cal diseases. Finally, to elucidate the problem as far as possible, we have also
studied the copper metabolism in a number of other diseases. The more ex·
tensive the material has become, however, the more variegated has been the
picture of copper metabolism, so that the present results must be regarded as
only a provisional communication, while the ~.vork continues.
We will first examine the state of affairs in hypercupraemia, which is the
most usual shift in copper content.
Our studies have confirmed the well·known observations reported in the
literature, that the copper content is elevated in acute and chronic infections.
In addition, we could confirm the observation of an increase in copper with
increased metabolism. Our results have varied considerably, and we are unable
to say whether there is a parallelism between increase in metabolism and in-
crease in amount of copper. This result is in agreement with the observations
made by HEILMEYER in 1941.
In most cases, the rise in serum· copper was accompanied by a rise in
ceruloplasmin content, without an even approximately as great increase in the
copper content of erythrocytes or leucocytes.
An examination of the copper content of the blood in patients with malig-
nant tumors showed an increase in serum copper, with normal or at times
slightly reduced erythrocyte copper. There was, however, an exception with
mammary cancer, in which the same rise in copper was found in both serum
and erythrocytes, at the same time with a slight rise in the copper content of
the leucocytes.
The serum copper seems to be distributed in the same way as under normal
conditions, so that most of it is bound to globulins. There is some discussion as
to how this increased amount of copper should be explained. Many consider
that it should be interpreted as the reaction of the organism to foreign proteins.
6
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This explanation is used by HEILMEYER in interpreting hypercupraemia in pre-
gnancy, and by BRAUN-STAPPENBECK likewise in malignant tumors. The ques-
tion is, however, not clarified, for one thing there seems to be no parallelism
at all between the duration of the disease, its degree of severity and the serum
copper content.
According to the literature, increased copper in the serum is also found in
the following diseases: lupus erythematosus disseminatus, glomerulone-
phritis, rheumatoid arthritis and rheumatic fever.
A study of 15 patients with rheumatoid arthritis showed a rise in serum
copper and at the same time a rise in both ceruloplasmin content and copper
oxidase activity, while the content of copper in the erythrocytes rose only
slightly.
The literature reports variations in serum copper and ceruloplasmin content
in myocardial infarctions. We have unfortunately had no opportunity of ex-
amining this.
In leukaemia, we observed a rise in serum copper, while the erythrocyte
copper level values remained around normal. A slight reduction in copper con-
tent is found in the leucocytes, although the values found cannot be regarded
as statistically significant, both because of the limited material and because of
the considerable spread observed in the normal group and the patient material.
The literature reports increased serum copper in a variety of forms of
anaemia, being observed frequently in pernicious anaemia, aplastic anaemia
and iron-deficiency anaemia. The copper content of the leucocytes is not reported
to have altered during these diseases. In our studies of patients with pernicious
anaemia we found a slightly increased content of copper in serum, whole blood
and erythrocytes, just as this was also found in the leucocytes, but here the
percentage increase was not so great as with the erythrocytes. A third of the
patients examined, in spite of their rise in serum copper, showed a reduced
amount of ceruloplasmin and reduced copper oxidase activity, just as can be
observed in patients with multiple sclerosis.
In diseases of the liver, such as portal cirrhosis, both serum copper and
ceruloplasmin are found to rise, but in this case it is found that the copper which
is not combined in the ceruloplasmin, increases in parallel with the rise in the
ceruloplasmin, in contrast to the findings in a number of the previously men-
tioned diseases.
Increased serum copper was found on examining a number of patients with
schizophrenia. Thi.s finding; confirms a number of previous reports, but there
is still some discussion on this increase, as it has not been demonstrated in some
other studies, just as discussion continues on whether a rise in the copper oxidase
activity takes place at the same time. Our own observations also vary con-
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siderably, as a number of the patients examined show quite normal conditions
with regard to ceruloplasmin and copper oxidase activity, while others show a
clear rise. It should also be emphasized that repeated studies of the same patient
at intervals of some weeks have been able to show both normal and increased
levels of copper oxidase activity. These findings can be interpreted as signifying
that the rises in serum copper and copper oxidase activity are not anything
specific for the disease, but that in a patient with schizophrenia the copper me-
tabolism as a whole is out of balance.
In addition to these studies, we have examined a large number of patients
with multiple sclerosis. The first investigations were concerned mainly with the
determination of total serum copper and ceruloplasmin content, and the results
were presented at the Tokyo Haematology Congress in 1960.
These studies were continued later and extended by studies of the copper
content of erythrocytes and leucocytes.
A few workers report that a slightly reduced copper oxidase activity is
found in multiple sclerosis, while others report normal conditions.
We examined 90 patients with multiple sclerosis and found a reduced cop-
per oxidase activity, compared to the results from 125 analyses in normal sub-
jects.
As a measure of oxidase activity, we used the optical density in all our
investigations, determined by HOUCHIN'S method (1958). The average value
obtained for our normal material was 0.283, while for the patients with multiple
sclerosis it was found to be only 0.204. The difference was shown to be statis-
tically significant. As mentioned before, the copper oxidase activity in cases of
pernicious anaemia was found to be decreased in one third of the cases, just as
in the patients with multiple sclerosis.
Alongside the determination of copper oxidase activity determinations were
made of the ceruloplasmin amount. This was found to be clearly reduced in the
patients with multiple sclerosis, while only one third of the patients with per-
nicious anaemia, as mentioned above, showed a decrease. The average value
for the normal material was 37 mg ceruloplasmin per 100 ml, while in patients
with multiple sclerosis the average was only 23 mg per 100 m!.
In addition to these studies of serum copper, determinations were made of
copper in erythrocytes and leucocytes in 22 patients. Reduced copper amounts
were found in the leucocytes in a number of the patients, while the copper in
the erythrocytes was found ir\creased.
However, the material in these studies is too small to permit any definite
conclusions from the findings, but the investigations are being continued.
As I mentioned previously, cases of hypocupraemia are also found. The
most frequently studied disease showing this disturbance in copper metabolism
8
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is Wilson's disease. Unfortunately, I have not myself had the opportunity of
examining patients with this disease, as the last patient suffering from the disease
in Denmark died about 15 years ago in our hospital. The literature shows that
in such cases, a reduction in serum copper of more than 50 per cent may be
involved.
Among other diseases in which a reduction in copper amount is found might
be mentioned sprue and dysproteinaemia. In addition, a series of observations
of reduced copper levels in the serum have been made in "the nephrotic syn-
drome".
From discussing variations in' the amount of one "trace element" in the
blood, copper, let us turn to considerations of another of these trace elements,
zinc.
Zinc as a pure metal has been known of only relatively recent date, its first
description as a chemically pure element being from about 1600. The metal is
widespread in the earth's crust, to an amount quoted as 0.004 per cent. The
element appears to have vital importance for the growth of both plants and
animals.
Interest for zinc in human pathology first arose about 50 years ago, but
since then, numerous studies have been made of its occurrence and functions,
although it must be admitted that studies of the disturbances in its values which
can be found in pathological states are still limited.
One of the best studied compounds of zinc is undoubtedly insulin, but this
lies outside the scope of the topic to be discussed here in this paper.
Table 4. Zinc metalloenzymes of known metal content.
Enzyme I Zinc 0/0 I Mol. Wt.
Carbonic anhydrase (bovine erythrocytes) ............ 0.1-0.3 30 000
Carboxypeptidase (bovine pancreas) .................. 0.18 13 300
Alcohol dehydrogenase (yeast) ........................... 0.18 150 000
Alcohol dehydrogenase (equine liver) ..................
•
0.18 73 000
Glutamic dehydrogense (bovine liver) .................. 0.2-0.3 1 000 000
Lactic dehydrogenase (rabbit skeletal muscle) ...... 0.07 ?
Alkaline phosphatase (porcine kidney) ............... I 0.15 ?
The human organism contains a total of approximately 2 grams of zinc.
The highest concentration is found in the testes, hair and bones; the lowest
concentration is found in the brain and blood.
There is thus no relation between the amounts of zinc and copper in the
various organs.
Examining the zinc concentration in the blood, it is found in both serum
and blood corpuscles. Serum contains 15 per cent of the zinc, found in blood
9
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in the form of two components. The one, the lesser part, about one third of
the serum zinc, is probably bound to globulin, while the other, greater part is
loosely bound to albumin and represents "the transport zinc".
The other 85 per cent of the zinc is found in the erythrocytes.
The leucocytes also contain a certain amount of zinc. A protein can be
extracted from the leucocytes, containing about 0.3 per cent zinc. This amounts
to 80 per cent of the zinc in the leucocytes. An enzymatic compound is involved,
but "the nature of its enzymatic activity is not known". All that is known, is
that its function differs considerably from that of "carbonic anhydrase". So .far,
no fewer than 7 zinc metallo-enzymes have been separated from animal tissues,
as shown in Table 4. As mentioned, our present knowledge of these substances
is very limited, but the observations which have been made appear to confirm
that metal enzyme complexes are involved, rather than metallo·enzymes.
Much of the information available on zinc metabolism comes from studies
of the zinc content of the blood.
In spite of the scanty literature and the considerable variation between the
observations of different workers, it may be stated with more or less certainty,
as also confirmed by our own observations, that under normal conditions, about
85 per cent of the zinc in the blood is found in the erythrocytes, while 2-3 per
cent is found in the leucocytes, and the remainder, about 10 per cent, is found
in the serum. The analyses also show that no definite difference can be demon-
strated in the zinc content between men and women, as was the case with
copper. Variations in the zinc concentration of the blood can be found, just as
with copper, but these variations do not always run parallel between the two
elements.
Reduced zinc values can often be found in acute and chronic infections. A
clear relation is seen between the rise in temperature and the fall in zinc level,
so that the lowest zinc values are found with the hightest temperature.
Studies of a number of patients with malignant tumors showed likewise a
reduction in serum zinc combined with a significant fall in the amount of zinc
in the erythrocytes and a quite slight fall in the leucocyte content. The fall
seemed most pronounced in the cases of mammary cancer, in which the most
pronounced rises in copper content were found.
In the analysis of blood from patients with simple anaemias, we have been
unable to demonstrate definite variations in the serum zinc content, as reported
by other authors, while in our studies of cases of pernicious anaemia, we have
observed a clear fall in the serum zinc. erythrocyte zinc and leucocyte zinc.
The blood of patients with multiple sclerosis also shows a clear reduction
in the zinc content of serum, erythrocytes and leucocytes, just as in pernicious
flnaemia,
10
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Table 5. The zinc content of serum, whole blood, erythrocytes and leucocytes in
normal and pathological cases.
313
! Whole blood I Erythrocytes
Diagnosis
Serum
Average
(min-max)
Gamma pr 100 ml
I Average I(min-max)
Average
(min·max)
I Leucocytes
I
Gamma pr
109 cells
I
Average
(min-max)
Controls, male .
- female··················
Anemia simplex .
- perniciosa .
25
25
5
11
131
(80-169)
129
(78-160)
121 I
(61-17~)
103
(59-141)
686
(512-802)
605
(507-739)
625
(492-776)
541
(456-614)
1312
(1058-1688)
1210
(1045-1463)
1241
(1012-1493)
1198
(1027-1304)
29
(17-46)
30
(16-51)
27
(16-13)
22
(12-31)
Leukemia acute I 2
- chr. 6
88
(45-121)
100
(55-130)
392 1014 10
(296-470) (820-1204) (7-13)
433 1126 14
(319-483) (873-1216) (6-21)
Various neurol. diseases.. ·
Tuberculosis pulm .
i
121 129 I 652 I 1292 I 30
1 ---:_----:-_(8_5-_1_51_)-;-._(5_4_1-_75_2_)-;-._(_10_7_2-_14_2_2-;)_ (16-~
1
1
151' 131 I 651 I 1281 I 29
(61-152) (556-842) (1156-1402) (15-39)
Epilepsy· .. ·.... ·.. ·.. ·· .. · .... ·
Multiple Sclerosis.. ·........ ·
Psychosis et Neurosis ......
Schizophrenia ..
1
10 I 139 I 729 I 1369 I 34
(97-181) (582-879) (1172-1690) (21-53)
I 12 1 112 I 593 I 1178 I 25I (60-133) (478-663) I (957-1283) (12-34)
1
11 I 133 I 699 I 1371 I 30
(78-162) I (567-783) (1137-1524) (16-39)
I
51 135 I 651 I 1231 I 29
(83-157) (561-772) (1127-1462) (15-50)
Cancer uteri ..
.,. mammae...... ·.. · .... ·
10
3
106
(65-146)
98
(60-124)
576 1278 22
(512-658) (1166-1392) (10-31)
521 1149 20
(472-567) (1072-1226) (9-30)
During pregnancy, there is a clear reduction in the zinc concentration in
the mother, while the foetal blood shows a high concentration. This is the exact
opposite of the findings with copper.
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The possibilities of significant interactions among the trace elements in
human and animal physiology, have not received the attention which they
undoubtedly deserve, in spite of the considerable body of knowledge indicating
the importance of such interactions in the nutrition of plants.
A few studies have been undertaken on the effects of one element in coun-
teracting the toxic effects of excessive intakes of another, such as copper in zinc
and molybdenum toxicity, and on the influence of comparatively massive intake
of one element on the absorption of another, such as phosphate on iron and
manganese uptake. Until recently, however, little evidence has been presented
to suggest that there is an interrelationship between the amounts of the trace
elements required by animals and human beings, or between their metabolism
within the body, at physiological and pathological levels.
Among the earliest of such physiological interactions to be revealed was
that between iron and copper. Both these elements are concerned, as one of
their functions, with hematopoiesis, so that a deficiency of one will clearly limit
the requirement of the other. It is usually stated that copper is necessary for the
iron utilization in blood formation, but iron must also be necessary for copper
utilization, at least to the extent that copper is concerned in hematopoiesis. It
is well-known from studies carried out on animals that an inhibiting effect of
molybdenum on copper retention is markedly influenced by the level of inorganic
sulphate. From this it will be clear that the studies of copper metabolism and
copper requirements are of little value unless the molybdenum and inorganic
sulphate levels in the diet are known. Further it has been shown in animals
that the copper requirement is greatly affected by the level of the dietary zinc
and so on. As mentioned, however, most examinations and experiments are
carried out on animals, and so far we know very little about the interaction of
the trace elements in hurnan pathology. In any case it is obvious that consider-
able caution should be exercised in the interpretation of nutritional and metabolic
studies of the trace elements, in which attention is restricted to a single element
only.
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